Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Uncover effective wealth building strategies in tough economic times to ensure your financial success. Start planning today!
19,592 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A federal court in Tennessee blocked state enforcement actions against Kalshi, citing a likelihood the contracts may ...
A pivotal license extension in Ghana fuels a surge in Kosmos Energy. This article breaks down what the move means for...
Two private-credit funds unveiled exit options for locked-up investors, offering steep discounts and renewed liquidit...
Ethereum has seen price swings as reports surface that ethereum founder vitalik buterin has been selling portions of ...
A new AI-driven marketing platform is raising Reg A+ funds at $0.85 per share, pitching a fast-growth TMT play for in...
Earnings season is a chance to gauge WLKP's momentum and risk. This guide shows investors how to read the WLKP report...
ARTY posted a 12-month gain of 28.3%, topping QQQ's 14.3% and SPY's 13.7%, as AI infrastructure exposure draws buyers...
NVIDIA beat estimates with $68.1 billion in Q4 revenue and strong Q1 guidance, led by data-center demand. Analysts we...
IMAX stock is showing fresh strength after a solid quarterly beat and a clear path to bigger earnings from its premiu...
A veteran mortgage executive leaves loanDepot to launch Trust One Financial, a new broker-focused lender backed by Ea...
A joint U.S.-Israel strike on Iran sent shockwaves through energy and financial markets as Tehran signaled retaliatio...